Patients report increased control and decreased impact of heart failure during pulmonary pressure-guided management.

ABSTRACT:

Aims

This study investigated Class III heart failure patient experience with pulmonary artery pressure (PAP) monitoring over 24 months including (1) changes in reported quality of life (QoL), (2) changes in HF illness perception and sense of control (control), (3) patient evaluation of PAP-guided therapy as a modality and (4) behavioural adherence to remote monitoring.

Methods and results

A 272 patient subgroup from the N = 1200 patient CardioMEMS™ Post-Approval Study completed 3 questionnaires including HF-related QoL, illness perception and control, and PAP therapy evaluation. Patient measurement frequency was also collected as a behavioural adherence index. Patient perception of illness was assessed via a general linear mixed model to account for all data available at all

SUBMITTER: Rathman LD 

PROVIDER: S-EPMC12450827 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature